European strategy for influenza A/H1N1 vaccine benefit-risk monitoring

The European Medicines Agency (EMEA), the European Centre for Disease Prevention and Control (ECDC) and the Heads of Medicines Agencies, in October 2009, adopted a strategy to further strengthen the coordination of benefit-risk monitoring for influenza A/H1N1 vaccines. The strategy was published on the EMEA website on 5 November 2009.

• Primary Source

ECDC: Influenza vaccination http://www.ecdc.europa.eu/en/healthtopics/Pages/Influenza_Vaccination.aspx

---